Skip to main content
SpringerLink
Log in

Cannabidiol: de nieuwe haarlemmerolie of een hype?

  • Middelen
  • Published:
Verslaving

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figuur 1
Figuur 2

Notes

  1. Oorspronkelijk werd wiet aangeduid als marihuana.

Literatuur

  • Barkus, E., & Murray, R.M. (2010). Substance use in adolescence and psychosis: clarifying the relationship.Annual Review of Clinical Psychology, 6,365–389.

    Article  PubMed  Google Scholar 

  • Bergamaschi, M.M., Queiroz, R.H., Chagas, M.H., De Oliveira, D.C., De Martinis, B.S., Kapczinski, F., Quevedo, J., Roesler, R., Schroder, N., Nardi, A.E., Martin-Santos, R., Hallak, J.E., Zuardi, A.W., & Crippa, J.A. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatmentnaive social phobia patients.Neuropsychopharmacology, 36,1219–1226.

    Article  PubMed  CAS  Google Scholar 

  • Bhattacharyya, S., Morrison, P.D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O’Carroll, C.M., Seal, M., Allen, P., Mehta, M.A., Stone, J.M., Tunstall, N., Giampietro, V., Kapur, S., Murray, R.M., Zuardi, A.W., Crippa, J.A., Atakan, Z., & McGuire, P.K. (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.Neuropsychopharmacology, 35,764–774.

    Article  PubMed  CAS  Google Scholar 

  • Bisogno, T., Hanus, L., DePetrocellis, L., Tchilibon, S., Ponde, D.E., Brandi, I., Moriello, A.S., Davis, J.B., Mechoulam, R., & Di Marzo, V. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.British Journal of Pharmacology, 134,845–852.

    Article  PubMed  CAS  Google Scholar 

  • Campos, A.C., & Guimaraes, F.S. (2008). Involvement of 5HT1A receptors in the anxiolytic- like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats.Psychopharmacology (Berl), 199,223–230.

    Article  CAS  Google Scholar 

  • Caspi, A., Moffitt, T.E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R., & Craig, I.W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.Biological Psychiatry, 57,1117–1127.

    Article  PubMed  CAS  Google Scholar 

  • Crippa, J.A., Zuardi, A.W., Martin-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: a critical review of the evidence.Human Psychopharmacology, 24,515–523.

    Article  PubMed  CAS  Google Scholar 

  • D’Souza, D.C. (2007). Cannabinoids and psychosis.International Reviews in Neurobiology, 78,289–326.

    Article  Google Scholar 

  • D’Souza, D.C., Sewell, R.A., & Ranganathan, M. (2009). Cannabis and psychosis/ schizophrenia: human studies.European Archives of Psychiatry and Clinical Neuroscience, 259,413–431.

    Article  PubMed  Google Scholar 

  • De Petrocellis, L., & Di Marzo., V. (2010). Non-CB1, non-CB2-receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.Journal of Neuroimmune Pharmacology, 5,103–121.

    Article  PubMed  Google Scholar 

  • Degenhardt, L., Roxburgh, A., & McKetin, R. (2007). Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.Medical Journal of Australia, 186,342–345.

    PubMed  Google Scholar 

  • Demirakca, T., Sartorius, A., Ende, G., Meyer, N., Welzel, H., Skopp, G., Mann, K., & Hermann, D. (2011). Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol.Drug and Alcohol Dependence, 114,242–245.

    PubMed  CAS  Google Scholar 

  • Di Forti M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T.R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S.A., Wiffen, B., Powell, J., & Murray, R.M. (2009). High-potency cannabis and the risk of psychosis.British Journal of Psychiatry, 195,488–491.

    Article  PubMed  Google Scholar 

  • Dragt, S., Nieman, D.H., Schultze-Lutter, F., Meer, F. van der, Becker, H., Haan, L. de, Dingemans, P.M., Birchwood, M., Patterson, P., Salokangas, R.K., Heinimaa, M., Heinz, A., Juckel, G., Graf von Reventlow, H., French, P., Stevens, H., Ruhrmann, S., Klosterkotter, J., & Linszen, D.H. (2012). Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.Acta Psychiatrica Scandinavia, 125,45–53.

    Article  CAS  Google Scholar 

  • Field, M., Eastwood, B., Bradley, B.P., & Mogg, K. (2006). Selective processing of cannabis cues in regular cannabis users.Drug and Alcohol Dependence, 85,75–82.

    Article  PubMed  Google Scholar 

  • Fischedick, J., Kooij, F. van der, & Verpoorte, R. (2010). Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.Chemical Pharmacological Bulletin (Tokyo), 58,201–207.

    Article  CAS  Google Scholar 

  • Gaoni, Y., & Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society 86,1646–1647.

    Article  CAS  Google Scholar 

  • Grotenhermen, F. (2004). Pharmacology of cannabinoids.Neurology and Endocrinology Letters, 25,14–23.

    CAS  Google Scholar 

  • Hampson, A.J., Grimaldi, M., Lolic, M., Wink, D., Rosenthal, R., & Axelrod, J. (2000). Neuroprotective antioxidants from marijuana.Annual of the New York Academy of Science, 899,274–282.

    Article  CAS  Google Scholar 

  • Harvey, B.S., Ohlsson, K.S., Maag, J.L., Musgrave, I.F., & Smid, S.D. (2012). Contrasting protective effects of cannabinoids against oxidative stress and amyloidbeta evoked neurotoxicity in vitro.Neurotoxicology, 33,138–146.

    Article  PubMed  CAS  Google Scholar 

  • Harvey, D.J., Samara, E., & Mechoulam, R. (1991). Comparative metabolism of cannabidiol in dog, rat and man.Pharmacology Biochemistry and Behavior, 40,523–532.

    Article  CAS  Google Scholar 

  • Howlett, A.C., Johnson, M.R., Melvin, L.S., & Milne, G.M. (1988). Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.Molecular Pharmacology, 33,297–302.

    PubMed  CAS  Google Scholar 

  • Hunault, C.C., Mensinga, T.T., Bocker, K.B., Schipper, C.M., Kruidenier, M., Leenders, M.E., Vries, I. de, & Meulenbelt, J. (2009). Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).Psychopharmacology (Berl), 204,85–94.

    Article  CAS  Google Scholar 

  • Karschner, E.L., Darwin, W.D., McMahon, R.P., Liu, F., Wright, S., Goodwin, R.S., & Huestis, M.A. (2011). Subjective and physiological effects after controlled Sativex and oral THC administration.Clinical Pharmacology and Therapeutics, 89,400–407.

    Article  PubMed  CAS  Google Scholar 

  • Large, M., Sharma, S., Compton, M.T., Slade, T., & Nielssen, O. (2011). Cannabis use and earlier onset of psychosis: a systematic meta-analysis.Archives of General Psychiatry, 68,555–561.

    Article  PubMed  Google Scholar 

  • Lastres-Becker, I., Molina-Holgado, F., Ramos, J.A., Mechoulam, R., & Fernandez-Ruiz, J. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease.Neurobiological Diseases, 19,96–107.

    Article  CAS  Google Scholar 

  • Ligresti, A., Cascio, M.G., Pryce, G., Kulasegram, S., Beletskaya, I., DePetrocellis, L., Saha, B., Mahadevan, A., Visintin, C., Wiley, J.L., Baker, D., Martin, B.R., Razdan, R.K., & Di Marzo, V. (2006). New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis.British Journal of Pharmacology, 147,83–91.

    Article  PubMed  CAS  Google Scholar 

  • Linszen, D.H., Dingemans, P.M., & Lenior, M.E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders.Archives of General Psychiatry, 51,273–279.

    Article  PubMed  CAS  Google Scholar 

  • Mechoulam, R., & Carlini, E.A. (1978). Toward drugs derived from cannabis.Naturwissenschaften, 65,174–179.

    Article  PubMed  CAS  Google Scholar 

  • Mechoulam, R., & Shvo, Y. (1963). The structure of cannabidiol.Tetrahedron 19, 2073-2078.

  • Mercier, B., Prost, J., & Prost, M. (2009). The essential oil of turpentine and its major volatile fraction (alpha- and beta-pinenes): a review.International Journal of Occupational Medicine and Environmental Health, 22,331–342.

    Article  PubMed  Google Scholar 

  • Moreira, F.A., & Wotjak, C.T. (2010). Cannabinoids and anxiety.Current Topics in Behavioral Neuroscience, 2,429–450.

    Article  Google Scholar 

  • Morgan, C.J., & Curran, H.V. (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.British Journal of Psychiatry, 192,306–307.

    Article  PubMed  Google Scholar 

  • Morgan, C.J., Freeman, T.P., Schafer, G.L., & Curran, H.V. (2010). Cannabidiol attenuates the appetitive effects of delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.Neuropsychopharmacology, 35,1879–1885.

    Article  PubMed  CAS  Google Scholar 

  • Morgan, C.J., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T.P., Warrington, P., Rupasinghe, I., Ramoutar, A., Tan, N., Wingham, G., Lewis, S., & Curran, H.V. (2012). Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.Psychological Medicine,42,1–10.

    Article  Google Scholar 

  • Morgan, C.J., Schafer, G., Freeman, T.P., & Curran, H.V. (2009). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].British Journal of Psychiatry, 197,285–290.

    Article  Google Scholar 

  • Niesink, R.J.M., & Laar, M. van (2012).THC, CBD en gezondheidseffecten van wiet en hasj. Recente inzichten. Utrecht: Trimbos-instituut.

    Google Scholar 

  • Ramaekers, J.G., Berghaus, G., Laar, M. van, & Drummer, O.H. (2004). Dose related risk of motor vehicle crashes after cannabis use.Drug and Alcohol Dependence, 73,109–119.

    Article  PubMed  CAS  Google Scholar 

  • Ranganathan, M., & D’Souza, D.C. (2006). The acute effects of cannabinoids on memory in humans: a review.Psychopharmacology (Berl), 188,425–444.

    Article  CAS  Google Scholar 

  • Rigter, S., & Niesink, R. (2011).THC-concentraties in wiet, nederwiet en hasj in Nederlandse coffeeshops (2010-2011). Utrecht: Trimbos-instituut.

    Google Scholar 

  • Rosenthal, E. (2001).The big book of buds. Oakland, CA: Quick American Archives.

    Google Scholar 

  • Russo, E.B., Burnett, A., Hall, B., & Parker, K.K. (2005). Agonistic properties of cannabidiol at 5-HT1a receptors.Neurochemical Research, 30,1037–1043.

    Article  PubMed  CAS  Google Scholar 

  • Schubart, C.D., Gastel, W.A. van, Breetvelt, E.J., Beetz, S.L., Ophoff, R.A., Sommer, I.E., Kahn, R.S., & Boks, M.P. (2010). Cannabis use at a young age is associated with psychotic experiences.Psychological Medicine,40,1–10.

    Article  Google Scholar 

  • Scuderi, C., Filippis, D.D., Iuvone, T., Blasio, A., Steardo, A., & Esposito, G. (2009). Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.Phytotherapy Research, 23,597–602.

    Article  PubMed  CAS  Google Scholar 

  • Wiers, R. (2009). Automatische en controleerbare processen en het ontstaan van verslaving. In I. Franken & W. van den Brink (Eds.),Handboek verslaving (pp.115–134). Utrecht: De Tijdstroom.

    Google Scholar 

  • Winton-Brown, T.T., Allen, P., Bhattacharyya, S., Borgwardt, S.J., Fusar-Poli, P., Crippa, J.A., Seal, M.L., Martin-Santos, R., Ffytche, D., Zuardi, A.W., Atakan, Z., & McGuire, P.K. (2011). Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.Neuropsychopharmacology, 36,1340–1348.

    Article  PubMed  CAS  Google Scholar 

  • Zuardi, A.W. (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.Revista Brasileira de Psiquiatria, 30,271–280.

    Article  PubMed  Google Scholar 

  • Zuardi, A.W., Guimaraes, F.S., & Moreira, A.C. (1993). Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers.Brazilian Journal of Medical Biological Research, 26,213–217.

    CAS  Google Scholar 

  • Zuardi, A.W., Shirakawa, I., Finkelfarb, E., & Karniol, I.G. (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.Psychopharmacology (Berl), 76,245–250.

    Article  CAS  Google Scholar 

  • Zuurman, L., Roy, C., Schoemaker, R.C., Hazekamp, A., Hartigh, H.J. den, Bender, J.C., Verpoorte, R., Pinquier, J.L., Cohen, A.F., & Gerven, J.M. van (2008).Effect of intrapulmonary tetrahydrocannabinol administration in humans.Journal of Psychopharmacoly, 22,707–716.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculteit Natuurwetenschappen, Universiteit Nederland, Breda, The Netherlands

    R. J. M. Niesink

  2. Trimbos-instituut te Utrecht, Utrecht, The Netherlands

    R. J. M. Niesink

  3. Trimbos-instituut, Utrecht, The Netherlands

    M.W. van Laar

Authors
  1. R. J. M. Niesink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.W. van Laar
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dit artikel is (deels) gebaseerd op een literatuurstudie die werd uitgevoerd in opdracht van het ministerie van Volksgezondheid,Welzijn en Sport (Niesink & Van Laar, 2012).

farmacoloog/toxicoloog en universitair hoofddocent, senior wetenschappelijk medewerker bij het Programma Drug Monitoring, landelijk coördinator van het Drugs Informatie en Monitoring Systeem

programmahoofd bij het Programma Drug Monitoring

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niesink, R.J.M., van Laar, M. Cannabidiol: de nieuwe haarlemmerolie of een hype?. VERSLAVING 8, 63–77 (2012). https://doi.org/10.1007/s12501-012-0020-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12501-012-0020-5

Search

Navigation